nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—Dacarbazine—pancreatic cancer	0.224	0.261	CbGbCtD
Thiabendazole—CYP1A1—Tamoxifen—pancreatic cancer	0.178	0.207	CbGbCtD
Thiabendazole—CYP1A1—Erlotinib—pancreatic cancer	0.151	0.176	CbGbCtD
Thiabendazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0999	0.116	CbGbCtD
Thiabendazole—CYP1A2—Tamoxifen—pancreatic cancer	0.0795	0.0926	CbGbCtD
Thiabendazole—CYP1A2—Erlotinib—pancreatic cancer	0.0676	0.0787	CbGbCtD
Thiabendazole—CYP1A2—Fluorouracil—pancreatic cancer	0.0586	0.0682	CbGbCtD
Thiabendazole—Hepatic failure—Tamoxifen—pancreatic cancer	0.00177	0.0125	CcSEcCtD
Thiabendazole—Hepatic failure—Erlotinib—pancreatic cancer	0.00175	0.0123	CcSEcCtD
Thiabendazole—Sensory loss—Fluorouracil—pancreatic cancer	0.0017	0.012	CcSEcCtD
Thiabendazole—Hepatic failure—Sunitinib—pancreatic cancer	0.00151	0.0107	CcSEcCtD
Thiabendazole—Hepatic failure—Gemcitabine—pancreatic cancer	0.00121	0.00857	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00121	0.00856	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.0012	0.00847	CcSEcCtD
Thiabendazole—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.00109	0.00772	CcSEcCtD
Thiabendazole—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00107	0.00753	CcSEcCtD
Thiabendazole—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00106	0.00749	CcSEcCtD
Thiabendazole—Visual impairment—Tamoxifen—pancreatic cancer	0.00106	0.00747	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00104	0.00734	CcSEcCtD
Thiabendazole—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00104	0.00733	CcSEcCtD
Thiabendazole—Erythema multiforme—Erlotinib—pancreatic cancer	0.00103	0.00725	CcSEcCtD
Thiabendazole—Flushing—Tamoxifen—pancreatic cancer	0.00102	0.0072	CcSEcCtD
Thiabendazole—Chills—Erlotinib—pancreatic cancer	0.000974	0.00688	CcSEcCtD
Thiabendazole—Hypoaesthesia—Sunitinib—pancreatic cancer	0.000935	0.00661	CcSEcCtD
Thiabendazole—Erythema multiforme—Sunitinib—pancreatic cancer	0.000889	0.00628	CcSEcCtD
Thiabendazole—Angioedema—Tamoxifen—pancreatic cancer	0.000873	0.00617	CcSEcCtD
Thiabendazole—Flushing—Sunitinib—pancreatic cancer	0.000873	0.00616	CcSEcCtD
Thiabendazole—Hepatic failure—Docetaxel—pancreatic cancer	0.000861	0.00608	CcSEcCtD
Thiabendazole—Leukopenia—Tamoxifen—pancreatic cancer	0.000855	0.00604	CcSEcCtD
Thiabendazole—Liver injury—Epirubicin—pancreatic cancer	0.000855	0.00604	CcSEcCtD
Thiabendazole—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00085	0.00601	CcSEcCtD
Thiabendazole—Chills—Sunitinib—pancreatic cancer	0.000844	0.00596	CcSEcCtD
Thiabendazole—Jaundice—Irinotecan—pancreatic cancer	0.000841	0.00594	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000833	0.00589	CcSEcCtD
Thiabendazole—Haematuria—Gemcitabine—pancreatic cancer	0.000801	0.00566	CcSEcCtD
Thiabendazole—Liver injury—Doxorubicin—pancreatic cancer	0.000791	0.00559	CcSEcCtD
Thiabendazole—Angioedema—Sunitinib—pancreatic cancer	0.000748	0.00528	CcSEcCtD
Thiabendazole—Visual impairment—Irinotecan—pancreatic cancer	0.000746	0.00527	CcSEcCtD
Thiabendazole—Anorexia—Tamoxifen—pancreatic cancer	0.000743	0.00525	CcSEcCtD
Thiabendazole—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.000738	0.00521	CcSEcCtD
Thiabendazole—Anorexia—Erlotinib—pancreatic cancer	0.000735	0.0052	CcSEcCtD
Thiabendazole—Leukopenia—Sunitinib—pancreatic cancer	0.000733	0.00518	CcSEcCtD
Thiabendazole—Coordination abnormal—Epirubicin—pancreatic cancer	0.000732	0.00517	CcSEcCtD
Thiabendazole—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000719	0.00508	CcSEcCtD
Thiabendazole—Flushing—Irinotecan—pancreatic cancer	0.000719	0.00508	CcSEcCtD
Thiabendazole—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000713	0.00504	CcSEcCtD
Thiabendazole—Convulsion—Sunitinib—pancreatic cancer	0.000709	0.00501	CcSEcCtD
Thiabendazole—Chills—Irinotecan—pancreatic cancer	0.000695	0.00491	CcSEcCtD
Thiabendazole—Dyspepsia—Tamoxifen—pancreatic cancer	0.000686	0.00485	CcSEcCtD
Thiabendazole—Dyspepsia—Erlotinib—pancreatic cancer	0.000679	0.0048	CcSEcCtD
Thiabendazole—Decreased appetite—Tamoxifen—pancreatic cancer	0.000678	0.00479	CcSEcCtD
Thiabendazole—Coordination abnormal—Doxorubicin—pancreatic cancer	0.000678	0.00479	CcSEcCtD
Thiabendazole—Chills—Gemcitabine—pancreatic cancer	0.000677	0.00478	CcSEcCtD
Thiabendazole—Fatigue—Tamoxifen—pancreatic cancer	0.000672	0.00475	CcSEcCtD
Thiabendazole—Decreased appetite—Erlotinib—pancreatic cancer	0.000671	0.00474	CcSEcCtD
Thiabendazole—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000665	0.0047	CcSEcCtD
Thiabendazole—Fatigue—Erlotinib—pancreatic cancer	0.000665	0.0047	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000638	0.00451	CcSEcCtD
Thiabendazole—Anorexia—Sunitinib—pancreatic cancer	0.000637	0.0045	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000631	0.00446	CcSEcCtD
Thiabendazole—Abdominal pain—Tamoxifen—pancreatic cancer	0.000616	0.00436	CcSEcCtD
Thiabendazole—Lymphadenopathy—Epirubicin—pancreatic cancer	0.000612	0.00432	CcSEcCtD
Thiabendazole—Abdominal pain—Erlotinib—pancreatic cancer	0.00061	0.00431	CcSEcCtD
Thiabendazole—Vision blurred—Fluorouracil—pancreatic cancer	0.000609	0.0043	CcSEcCtD
Thiabendazole—Leukopenia—Irinotecan—pancreatic cancer	0.000603	0.00426	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000591	0.00418	CcSEcCtD
Thiabendazole—Dyspepsia—Sunitinib—pancreatic cancer	0.000588	0.00415	CcSEcCtD
Thiabendazole—Leukopenia—Gemcitabine—pancreatic cancer	0.000588	0.00415	CcSEcCtD
Thiabendazole—Jaundice—Docetaxel—pancreatic cancer	0.000581	0.00411	CcSEcCtD
Thiabendazole—Hepatic failure—Epirubicin—pancreatic cancer	0.000581	0.0041	CcSEcCtD
Thiabendazole—Decreased appetite—Sunitinib—pancreatic cancer	0.000581	0.0041	CcSEcCtD
Thiabendazole—Leukopenia—Fluorouracil—pancreatic cancer	0.000578	0.00408	CcSEcCtD
Thiabendazole—Fatigue—Sunitinib—pancreatic cancer	0.000576	0.00407	CcSEcCtD
Thiabendazole—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000575	0.00406	CcSEcCtD
Thiabendazole—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000566	0.004	CcSEcCtD
Thiabendazole—Asthenia—Tamoxifen—pancreatic cancer	0.00056	0.00395	CcSEcCtD
Thiabendazole—Convulsion—Fluorouracil—pancreatic cancer	0.000559	0.00395	CcSEcCtD
Thiabendazole—Confusional state—Irinotecan—pancreatic cancer	0.000555	0.00392	CcSEcCtD
Thiabendazole—Asthenia—Erlotinib—pancreatic cancer	0.000554	0.00391	CcSEcCtD
Thiabendazole—Pruritus—Tamoxifen—pancreatic cancer	0.000552	0.0039	CcSEcCtD
Thiabendazole—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00055	0.00389	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000546	0.00386	CcSEcCtD
Thiabendazole—Pruritus—Erlotinib—pancreatic cancer	0.000546	0.00386	CcSEcCtD
Thiabendazole—Hepatic failure—Doxorubicin—pancreatic cancer	0.000537	0.0038	CcSEcCtD
Thiabendazole—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000536	0.00379	CcSEcCtD
Thiabendazole—Diarrhoea—Tamoxifen—pancreatic cancer	0.000534	0.00377	CcSEcCtD
Thiabendazole—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000533	0.00376	CcSEcCtD
Thiabendazole—Confusional state—Fluorouracil—pancreatic cancer	0.000531	0.00375	CcSEcCtD
Thiabendazole—Abdominal pain—Sunitinib—pancreatic cancer	0.000528	0.00373	CcSEcCtD
Thiabendazole—Diarrhoea—Erlotinib—pancreatic cancer	0.000528	0.00373	CcSEcCtD
Thiabendazole—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000527	0.00372	CcSEcCtD
Thiabendazole—Anorexia—Irinotecan—pancreatic cancer	0.000524	0.00371	CcSEcCtD
Thiabendazole—Visual impairment—Docetaxel—pancreatic cancer	0.000516	0.00364	CcSEcCtD
Thiabendazole—Dizziness—Tamoxifen—pancreatic cancer	0.000516	0.00364	CcSEcCtD
Thiabendazole—Hypotension—Irinotecan—pancreatic cancer	0.000514	0.00363	CcSEcCtD
Thiabendazole—Anorexia—Gemcitabine—pancreatic cancer	0.000511	0.00361	CcSEcCtD
Thiabendazole—Dizziness—Erlotinib—pancreatic cancer	0.00051	0.0036	CcSEcCtD
Thiabendazole—Erythema multiforme—Docetaxel—pancreatic cancer	0.000506	0.00358	CcSEcCtD
Thiabendazole—Anorexia—Fluorouracil—pancreatic cancer	0.000502	0.00355	CcSEcCtD
Thiabendazole—Hypotension—Gemcitabine—pancreatic cancer	0.000501	0.00354	CcSEcCtD
Thiabendazole—Flushing—Docetaxel—pancreatic cancer	0.000497	0.00351	CcSEcCtD
Thiabendazole—Vomiting—Tamoxifen—pancreatic cancer	0.000496	0.0035	CcSEcCtD
Thiabendazole—Hypotension—Fluorouracil—pancreatic cancer	0.000492	0.00348	CcSEcCtD
Thiabendazole—Hypersensitivity—Sunitinib—pancreatic cancer	0.000492	0.00348	CcSEcCtD
Thiabendazole—Rash—Tamoxifen—pancreatic cancer	0.000492	0.00347	CcSEcCtD
Thiabendazole—Dermatitis—Tamoxifen—pancreatic cancer	0.000491	0.00347	CcSEcCtD
Thiabendazole—Vomiting—Erlotinib—pancreatic cancer	0.000491	0.00347	CcSEcCtD
Thiabendazole—Somnolence—Irinotecan—pancreatic cancer	0.000489	0.00346	CcSEcCtD
Thiabendazole—Headache—Tamoxifen—pancreatic cancer	0.000489	0.00345	CcSEcCtD
Thiabendazole—Rash—Erlotinib—pancreatic cancer	0.000486	0.00344	CcSEcCtD
Thiabendazole—Dermatitis—Erlotinib—pancreatic cancer	0.000486	0.00343	CcSEcCtD
Thiabendazole—Dyspepsia—Irinotecan—pancreatic cancer	0.000484	0.00342	CcSEcCtD
Thiabendazole—Headache—Erlotinib—pancreatic cancer	0.000483	0.00342	CcSEcCtD
Thiabendazole—Chills—Docetaxel—pancreatic cancer	0.00048	0.00339	CcSEcCtD
Thiabendazole—Asthenia—Sunitinib—pancreatic cancer	0.000479	0.00339	CcSEcCtD
Thiabendazole—Decreased appetite—Irinotecan—pancreatic cancer	0.000478	0.00338	CcSEcCtD
Thiabendazole—Somnolence—Gemcitabine—pancreatic cancer	0.000476	0.00337	CcSEcCtD
Thiabendazole—Fatigue—Irinotecan—pancreatic cancer	0.000474	0.00335	CcSEcCtD
Thiabendazole—Pruritus—Sunitinib—pancreatic cancer	0.000473	0.00334	CcSEcCtD
Thiabendazole—Somnolence—Fluorouracil—pancreatic cancer	0.000468	0.00331	CcSEcCtD
Thiabendazole—Decreased appetite—Gemcitabine—pancreatic cancer	0.000466	0.00329	CcSEcCtD
Thiabendazole—Dyspepsia—Fluorouracil—pancreatic cancer	0.000464	0.00328	CcSEcCtD
Thiabendazole—Nausea—Tamoxifen—pancreatic cancer	0.000463	0.00327	CcSEcCtD
Thiabendazole—Fatigue—Gemcitabine—pancreatic cancer	0.000462	0.00326	CcSEcCtD
Thiabendazole—Nausea—Erlotinib—pancreatic cancer	0.000458	0.00324	CcSEcCtD
Thiabendazole—Decreased appetite—Fluorouracil—pancreatic cancer	0.000458	0.00324	CcSEcCtD
Thiabendazole—Diarrhoea—Sunitinib—pancreatic cancer	0.000457	0.00323	CcSEcCtD
Thiabendazole—Feeling abnormal—Irinotecan—pancreatic cancer	0.000453	0.0032	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00045	0.00318	CcSEcCtD
Thiabendazole—Dizziness—Sunitinib—pancreatic cancer	0.000442	0.00312	CcSEcCtD
Thiabendazole—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000442	0.00312	CcSEcCtD
Thiabendazole—Abdominal pain—Irinotecan—pancreatic cancer	0.000435	0.00307	CcSEcCtD
Thiabendazole—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000434	0.00307	CcSEcCtD
Thiabendazole—Vomiting—Sunitinib—pancreatic cancer	0.000425	0.003	CcSEcCtD
Thiabendazole—Rash—Sunitinib—pancreatic cancer	0.000421	0.00298	CcSEcCtD
Thiabendazole—Dermatitis—Sunitinib—pancreatic cancer	0.000421	0.00297	CcSEcCtD
Thiabendazole—Headache—Sunitinib—pancreatic cancer	0.000418	0.00296	CcSEcCtD
Thiabendazole—Leukopenia—Docetaxel—pancreatic cancer	0.000417	0.00295	CcSEcCtD
Thiabendazole—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000407	0.00288	CcSEcCtD
Thiabendazole—Hypersensitivity—Irinotecan—pancreatic cancer	0.000405	0.00286	CcSEcCtD
Thiabendazole—Convulsion—Docetaxel—pancreatic cancer	0.000404	0.00285	CcSEcCtD
Thiabendazole—Drowsiness—Epirubicin—pancreatic cancer	0.000402	0.00284	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000399	0.00282	CcSEcCtD
Thiabendazole—Nausea—Sunitinib—pancreatic cancer	0.000397	0.0028	CcSEcCtD
Thiabendazole—Asthenia—Irinotecan—pancreatic cancer	0.000395	0.00279	CcSEcCtD
Thiabendazole—Jaundice—Epirubicin—pancreatic cancer	0.000392	0.00277	CcSEcCtD
Thiabendazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000388	0.00274	CcSEcCtD
Thiabendazole—Asthenia—Gemcitabine—pancreatic cancer	0.000385	0.00272	CcSEcCtD
Thiabendazole—Haematuria—Epirubicin—pancreatic cancer	0.000384	0.00271	CcSEcCtD
Thiabendazole—Confusional state—Docetaxel—pancreatic cancer	0.000383	0.00271	CcSEcCtD
Thiabendazole—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00038	0.00269	CcSEcCtD
Thiabendazole—Pruritus—Gemcitabine—pancreatic cancer	0.000379	0.00268	CcSEcCtD
Thiabendazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000377	0.00266	CcSEcCtD
Thiabendazole—Diarrhoea—Irinotecan—pancreatic cancer	0.000376	0.00266	CcSEcCtD
Thiabendazole—Pruritus—Fluorouracil—pancreatic cancer	0.000373	0.00263	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—pancreatic cancer	0.000372	0.00263	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000369	0.00261	CcSEcCtD
Thiabendazole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000367	0.00259	CcSEcCtD
Thiabendazole—Dizziness—Irinotecan—pancreatic cancer	0.000364	0.00257	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—pancreatic cancer	0.000363	0.00256	CcSEcCtD
Thiabendazole—Anorexia—Docetaxel—pancreatic cancer	0.000363	0.00256	CcSEcCtD
Thiabendazole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000361	0.00255	CcSEcCtD
Thiabendazole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000359	0.00254	CcSEcCtD
Thiabendazole—Hypotension—Docetaxel—pancreatic cancer	0.000355	0.00251	CcSEcCtD
Thiabendazole—Haematuria—Doxorubicin—pancreatic cancer	0.000355	0.00251	CcSEcCtD
Thiabendazole—Vomiting—Irinotecan—pancreatic cancer	0.00035	0.00247	CcSEcCtD
Thiabendazole—Dizziness—Fluorouracil—pancreatic cancer	0.000348	0.00246	CcSEcCtD
Thiabendazole—Visual impairment—Epirubicin—pancreatic cancer	0.000348	0.00246	CcSEcCtD
Thiabendazole—Rash—Irinotecan—pancreatic cancer	0.000347	0.00245	CcSEcCtD
Thiabendazole—Dermatitis—Irinotecan—pancreatic cancer	0.000347	0.00245	CcSEcCtD
Thiabendazole—Headache—Irinotecan—pancreatic cancer	0.000345	0.00244	CcSEcCtD
Thiabendazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000341	0.00241	CcSEcCtD
Thiabendazole—Vomiting—Gemcitabine—pancreatic cancer	0.000341	0.00241	CcSEcCtD
Thiabendazole—Somnolence—Docetaxel—pancreatic cancer	0.000338	0.00239	CcSEcCtD
Thiabendazole—Rash—Gemcitabine—pancreatic cancer	0.000338	0.00239	CcSEcCtD
Thiabendazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000338	0.00239	CcSEcCtD
Thiabendazole—Tinnitus—Epirubicin—pancreatic cancer	0.000337	0.00238	CcSEcCtD
Thiabendazole—Headache—Gemcitabine—pancreatic cancer	0.000336	0.00237	CcSEcCtD
Thiabendazole—Flushing—Epirubicin—pancreatic cancer	0.000335	0.00237	CcSEcCtD
Thiabendazole—Vomiting—Fluorouracil—pancreatic cancer	0.000335	0.00237	CcSEcCtD
Thiabendazole—Dyspepsia—Docetaxel—pancreatic cancer	0.000335	0.00237	CcSEcCtD
Thiabendazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000332	0.00235	CcSEcCtD
Thiabendazole—Rash—Fluorouracil—pancreatic cancer	0.000332	0.00235	CcSEcCtD
Thiabendazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000332	0.00235	CcSEcCtD
Thiabendazole—Decreased appetite—Docetaxel—pancreatic cancer	0.000331	0.00234	CcSEcCtD
Thiabendazole—Headache—Fluorouracil—pancreatic cancer	0.00033	0.00233	CcSEcCtD
Thiabendazole—Fatigue—Docetaxel—pancreatic cancer	0.000328	0.00232	CcSEcCtD
Thiabendazole—Nausea—Irinotecan—pancreatic cancer	0.000327	0.00231	CcSEcCtD
Thiabendazole—Chills—Epirubicin—pancreatic cancer	0.000324	0.00229	CcSEcCtD
Thiabendazole—Visual impairment—Doxorubicin—pancreatic cancer	0.000322	0.00227	CcSEcCtD
Thiabendazole—Nausea—Gemcitabine—pancreatic cancer	0.000318	0.00225	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000316	0.00223	CcSEcCtD
Thiabendazole—Feeling abnormal—Docetaxel—pancreatic cancer	0.000313	0.00221	CcSEcCtD
Thiabendazole—Nausea—Fluorouracil—pancreatic cancer	0.000313	0.00221	CcSEcCtD
Thiabendazole—Tinnitus—Doxorubicin—pancreatic cancer	0.000312	0.0022	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000311	0.0022	CcSEcCtD
Thiabendazole—Flushing—Doxorubicin—pancreatic cancer	0.00031	0.00219	CcSEcCtD
Thiabendazole—Abdominal pain—Docetaxel—pancreatic cancer	0.000301	0.00212	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—pancreatic cancer	0.0003	0.00212	CcSEcCtD
Thiabendazole—Vision blurred—Epirubicin—pancreatic cancer	0.000296	0.00209	CcSEcCtD
Thiabendazole—Leukopenia—Epirubicin—pancreatic cancer	0.000281	0.00199	CcSEcCtD
Thiabendazole—Hypersensitivity—Docetaxel—pancreatic cancer	0.00028	0.00198	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—pancreatic cancer	0.000274	0.00194	CcSEcCtD
Thiabendazole—Asthenia—Docetaxel—pancreatic cancer	0.000273	0.00193	CcSEcCtD
Thiabendazole—Convulsion—Epirubicin—pancreatic cancer	0.000272	0.00192	CcSEcCtD
Thiabendazole—Pruritus—Docetaxel—pancreatic cancer	0.000269	0.0019	CcSEcCtD
Thiabendazole—Leukopenia—Doxorubicin—pancreatic cancer	0.00026	0.00184	CcSEcCtD
Thiabendazole—Diarrhoea—Docetaxel—pancreatic cancer	0.00026	0.00184	CcSEcCtD
Thiabendazole—Confusional state—Epirubicin—pancreatic cancer	0.000259	0.00183	CcSEcCtD
Thiabendazole—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000257	0.00181	CcSEcCtD
Thiabendazole—Convulsion—Doxorubicin—pancreatic cancer	0.000252	0.00178	CcSEcCtD
Thiabendazole—Dizziness—Docetaxel—pancreatic cancer	0.000252	0.00178	CcSEcCtD
Thiabendazole—Anorexia—Epirubicin—pancreatic cancer	0.000245	0.00173	CcSEcCtD
Thiabendazole—Vomiting—Docetaxel—pancreatic cancer	0.000242	0.00171	CcSEcCtD
Thiabendazole—Rash—Docetaxel—pancreatic cancer	0.00024	0.00169	CcSEcCtD
Thiabendazole—Hypotension—Epirubicin—pancreatic cancer	0.00024	0.00169	CcSEcCtD
Thiabendazole—Dermatitis—Docetaxel—pancreatic cancer	0.00024	0.00169	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—pancreatic cancer	0.000239	0.00169	CcSEcCtD
Thiabendazole—Headache—Docetaxel—pancreatic cancer	0.000238	0.00168	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000237	0.00168	CcSEcCtD
Thiabendazole—Somnolence—Epirubicin—pancreatic cancer	0.000228	0.00161	CcSEcCtD
Thiabendazole—Anorexia—Doxorubicin—pancreatic cancer	0.000226	0.0016	CcSEcCtD
Thiabendazole—Nausea—Docetaxel—pancreatic cancer	0.000226	0.0016	CcSEcCtD
Thiabendazole—Dyspepsia—Epirubicin—pancreatic cancer	0.000226	0.0016	CcSEcCtD
Thiabendazole—Decreased appetite—Epirubicin—pancreatic cancer	0.000223	0.00158	CcSEcCtD
Thiabendazole—Hypotension—Doxorubicin—pancreatic cancer	0.000222	0.00157	CcSEcCtD
Thiabendazole—Fatigue—Epirubicin—pancreatic cancer	0.000221	0.00156	CcSEcCtD
Thiabendazole—Feeling abnormal—Epirubicin—pancreatic cancer	0.000211	0.00149	CcSEcCtD
Thiabendazole—Somnolence—Doxorubicin—pancreatic cancer	0.000211	0.00149	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00021	0.00148	CcSEcCtD
Thiabendazole—Dyspepsia—Doxorubicin—pancreatic cancer	0.000209	0.00148	CcSEcCtD
Thiabendazole—Decreased appetite—Doxorubicin—pancreatic cancer	0.000206	0.00146	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—pancreatic cancer	0.000205	0.00145	CcSEcCtD
Thiabendazole—Abdominal pain—Epirubicin—pancreatic cancer	0.000203	0.00143	CcSEcCtD
Thiabendazole—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000196	0.00138	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000194	0.00137	CcSEcCtD
Thiabendazole—Hypersensitivity—Epirubicin—pancreatic cancer	0.000189	0.00134	CcSEcCtD
Thiabendazole—Abdominal pain—Doxorubicin—pancreatic cancer	0.000188	0.00133	CcSEcCtD
Thiabendazole—Asthenia—Epirubicin—pancreatic cancer	0.000184	0.0013	CcSEcCtD
Thiabendazole—Pruritus—Epirubicin—pancreatic cancer	0.000181	0.00128	CcSEcCtD
Thiabendazole—Diarrhoea—Epirubicin—pancreatic cancer	0.000176	0.00124	CcSEcCtD
Thiabendazole—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000175	0.00124	CcSEcCtD
Thiabendazole—Asthenia—Doxorubicin—pancreatic cancer	0.00017	0.0012	CcSEcCtD
Thiabendazole—Dizziness—Epirubicin—pancreatic cancer	0.00017	0.0012	CcSEcCtD
Thiabendazole—Pruritus—Doxorubicin—pancreatic cancer	0.000168	0.00119	CcSEcCtD
Thiabendazole—Vomiting—Epirubicin—pancreatic cancer	0.000163	0.00115	CcSEcCtD
Thiabendazole—Diarrhoea—Doxorubicin—pancreatic cancer	0.000162	0.00115	CcSEcCtD
Thiabendazole—Rash—Epirubicin—pancreatic cancer	0.000162	0.00114	CcSEcCtD
Thiabendazole—Dermatitis—Epirubicin—pancreatic cancer	0.000162	0.00114	CcSEcCtD
Thiabendazole—Headache—Epirubicin—pancreatic cancer	0.000161	0.00114	CcSEcCtD
Thiabendazole—Dizziness—Doxorubicin—pancreatic cancer	0.000157	0.00111	CcSEcCtD
Thiabendazole—Nausea—Epirubicin—pancreatic cancer	0.000152	0.00108	CcSEcCtD
Thiabendazole—Vomiting—Doxorubicin—pancreatic cancer	0.000151	0.00107	CcSEcCtD
Thiabendazole—Rash—Doxorubicin—pancreatic cancer	0.00015	0.00106	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—pancreatic cancer	0.00015	0.00106	CcSEcCtD
Thiabendazole—Headache—Doxorubicin—pancreatic cancer	0.000149	0.00105	CcSEcCtD
Thiabendazole—Nausea—Doxorubicin—pancreatic cancer	0.000141	0.000996	CcSEcCtD
